Edition:
India

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

53.00USD
16 Jan 2018
Change (% chg)

$1.35 (+2.61%)
Prev Close
$51.65
Open
$52.40
Day's High
$53.60
Day's Low
$52.15
Volume
53,062
Avg. Vol
81,457
52-wk High
$62.50
52-wk Low
$42.55

Chart for

About

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the... (more)

Overall

Beta: 2.32
Market Cap(Mil.): $1,690.48
Shares Outstanding(Mil.): 32.73
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.81 16.63
EPS (TTM): -- -- --
ROI: -- 14.96 33.78
ROE: -- 16.51 17.31

BRIEF-Cambrex & Astrazeneca Hold Ceremony To Mark Long-Term Supply Agreement At Karlskoga, Sweden Facility

* CAMBREX & ASTRAZENECA HOLD CEREMONY TO MARK LONG-TERM SUPPLY AGREEMENT AT KARLSKOGA, SWEDEN FACILITY Source text for Eikon: Further company coverage:

16 Jan 2018

BRIEF-Cambrex reports Q3 adjusted earnings per share $0.55 from continuing operations

* Q3 adjusted earnings per share $0.55 from continuing operations

07 Nov 2017

BRIEF-Cambrex appoints Gregory Brown to its board of directors

* Gregory B. Brown M.D. Appointed to the board of directors of Cambrex corporation

03 Nov 2017

BRIEF-Cambrex Corp invests $24 mln in a new facility

* ‍To invest $24 million in a new facility to manufacture highly potent APIs at its Charles City, Iowa plant​ Source text for Eikon: Further company coverage:

08 Aug 2017

BRIEF-Cambrex Corp Q2 revenue $134.6 million

* Q2 adjusted earnings per share $0.76 from continuing operations

04 Aug 2017

Earnings vs. Estimates